European Innovation Council

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

David Malo Jean

Director

Past deals in Early Venture Stage

Chipiron

Series A in 2025
Chipiron develops portable MRI technology that uses quantum sensing to produce three-dimensional anatomical images at ultra-low magnetic fields. The devices are lightweight, portable, and priced at about one-tenth of conventional MRI systems. The technology supports disease detection, diagnosis, and treatment monitoring, with a focus on brain-related conditions, and aims to reduce fatality rates by expanding access to MRI imaging in diverse clinical settings.

Astrape Networks

Grant in 2025
Astrape powers the future of datacenters: more bandwidth, less power.

Sparrow Quantum

Series A in 2025
Sparrow Quantum specializes in developing deterministic single-photon sources for advancing light-matter interfaces in quantum technologies. With a focus on high efficiency, purity, indistinguishability, and outcoupling, the company's technology is based on over two decades of research at the Niels Bohr Institute.

QuantWare

Series A in 2025
QuantWare is the global leader in quantum hardware, specializing in scalable quantum processors. It offers a unique 3D chip architecture that enables clients to build powerful quantum computers capable of tackling real-world challenges in fields like climate and life sciences.

Precisionlife

Grant in 2025
Precisionlife employs a unique approach to drive innovation in chronic diseases through precision medicine. It uses artificial intelligence to generate deep insights into disease biology, stratifying patient populations for novel drug targets, biomarkers, and repositioning candidates.

Stablepharma

Grant in 2025
Founded in 2012, Stablepharma specializes in developing processes for vaccine stabilization. Its flagship product, Stablevax, enables precise dosage pre-loading into syringes at manufacture, eliminating wastage. The company's technology platform converts existing vaccines and diagnostics into thermostable products, addressing global cold chain challenges.

MOA

Grant in 2025
MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.

Deeploy

Grant in 2025
Deeploy specializes in Machine Learning Operations (MLOps) software that enhances the accountability of AI models. Its core features include real-time monitoring, explainability tools, and compliance management, empowering organizations to maintain transparency and control over their AI systems.

QDI systems

Grant in 2025
QDI Systems B.V. is a startup based in Groningen, the Netherlands, focused on developing advanced imaging devices for medical applications using quantum dot technology. The company specializes in creating X-ray sensors that deliver high-contrast and high-resolution imaging, particularly for mammography, while also reducing radiation exposure for patients. QDI Systems aims to provide user-friendly quantum dot materials accompanied by comprehensive instructions for constructing high-performance imaging devices. By leveraging innovative technology, the company enhances the precision of medical imaging, enabling healthcare professionals to obtain critical diagnostic information efficiently and safely.

AlzeCure Pharma

Grant in 2025
AlzeCure Pharma is a Swedish pharmaceutical company dedicated to developing drug therapies targeting diseases affecting the central nervous system. Its primary focus lies in Alzheimer's disease, with five drug candidates at various stages of development.

Elicera Therapeutics

Grant in 2025
Elicera Therapeutics is a clinical-stage immuno-oncology company based in Sweden that focuses on developing innovative cell and gene therapies to treat cancer. The company’s portfolio includes four drug candidates: two oncolytic virus therapies, ELC-100 and ELC-201, and two CAR T-cell treatments, ELC-301 and ELC-401. Additionally, Elicera has developed a universal CAR T-cell technology platform named iTANK (ELC-001), designed to enhance the efficacy of CAR T-cell therapies by enabling a multi-targeted approach against solid tumors. With its commitment to advancing immune-based cancer treatments, Elicera Therapeutics aims to improve outcomes for patients facing various forms of cancer.

TENSIVE

Series A in 2025
TENSIVE s.r.l. is a biomedical company based in Milan, Italy, founded in 2012. It specializes in the development of innovative prostheses for natural breast reconstruction and augmentation. The company's products utilize biodegradable synthetic biomaterials and feature an internal micro-architecture that mimics blood vessel structures. These vascularized prostheses aim to enhance the quality of life for patients undergoing treatment for breast cancer, offering a solution that reduces the need for recurrent and costly surgical interventions. Through its focus on advanced biomaterials and design, TENSIVE seeks to provide effective and sustainable options for breast reconstruction.

Photon IP

Grant in 2025
Photon IP is a Dutch deeptech company based in Eindhoven. It specializes in developing advanced photonics technologies for various applications.

AQLAS

Grant in 2025
AQLAS is shaping the quantum future and discovering Next-Gen Lasers redefining quantum computing. Our high-quality hardware is set apart by its economical, compact, and efficient nature, thus paving the way for the proliferation of quantum computers.

Hervolution Therapeutics

Series A in 2024
Hervolution Therapeutics specializes in developing first-in-class immunotherapies targeting tumors by harnessing Human Endogenous Retroviral proteins (HERVs). The company pioneers innovative biotechnology solutions to combat hidden enemies within the human body.

ION-X

Series A in 2024
ION-X develops electric propulsion technology for small spacecraft and satellites. It focuses on a nanoscience-based thruster that ejects fully ionized particles to produce thrust, offering long service life and high modularity. The technology aims for scalable manufacturing with competitive production costs suitable for mass production, enabling customers to access the expanding aerospace market and pursue efficient, reliable propulsion for small platforms.

Onward

Grant in 2024
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

AISPECO

Grant in 2024
AISPECO is a Lithuanian company specializing in geospatial monitoring systems for helicopters, planes, UAVs, and terrestrial vehicles.

Quantune Technologies

Grant in 2024
Quantune Technologies is a deep tech startup specializing in optics and photonics technology. The company focuses on developing advanced infrared spectrometers that facilitate continuous and non-invasive health monitoring. By miniaturizing traditional laboratory equipment used for molecular analysis into compact modules, Quantune enables both biomedical consumer devices and industrial applications. This innovation allows clients to efficiently conduct real-time monitoring and analysis of chemical compounds and emissions, providing accessible solutions for a range of novel applications.

Turing College

Grant in 2024
Turing College operates as an online educational institution specializing in data science. It offers courses suitable for individuals of varying skill levels and employs an income share agreement model, allowing students to defer payment until they secure employment. The college collaborates with tech companies to co-create its curriculum, providing these partners with real-time student performance updates to facilitate expedited hiring decisions.

National University of Ireland, Maynooth

Grant in 2024
Maynooth University is internationally recognised for quality and value of Their research and scholarship and Their dedication and commitment to teaching and Their students. Part of the NUI and formally established as an autonomous university in 1997, Maynooth University traces its origins to the foundation of the Royal College of St. Patrick in 1795, drawing inspiration from a heritage that includes over 200 years of education and scholarship. The University is a place of lively contrasts. It is a modern institution, dynamic, rapidly-growing, research-led and engaged, yet grounded in historic academic strengths and scholarly traditions.

Hideez Group

Grant in 2024
Hideez Group is a cybersecurity company that designs authentication devices and software to secure physical and logical access. It develops hybrid hardware and software solutions, including the Hideez Key, a wireless authentication and password-management device that also handles RFID credentials and digital signatures. The solution relies on encrypted Bluetooth, RFID, and NFC technologies, with proprietary encryption protocols and platform-agnostic compatibility to complement existing vendors. It provides passwordless identity management software that consolidates authentication workflows, using proximity sensing, one-time passwords, smart cards, and full-day authentication to improve security, compliance, and operational efficiency for organizations.

Sequentia Biotech

Series A in 2024
Founded in 2013 by Walter Sanseverino and Riccardo Aiese Cigliano, Sequentia Biotech is a bioinformatics company that transforms genomic data into actionable knowledge for academic research, plant/animal breeding, and biomedicine. With over 30 clients and partners, including public/private research centers, companies, and hospitals, Sequentia participates in more than 160 R&D projects and maintains two open-source biodata banks.

Ephos

Grant in 2024
Ephos specializes in developing integrated photonic circuits using glass technology. Its focus is on minimizing signal loss and enabling innovative device designs for classical and quantum computing applications, communications, and sensing. The company's proprietary manufacturing process ensures high-quality production tailored to client needs in the computational infrastructure sector.

Reverion

Series A in 2024
Reverion develops reversible, carbon-negative power plants using patented technology. Their containerized units achieve electrical efficiencies of up to 80%, doubling the electricity output of conventional gas engines while reducing greenhouse gas emissions and achieving a negative CO2 balance.

Treble

Series A in 2024
Treble Technologies is a company that focuses on advanced wave-based sound simulation products tailored for the architecture, engineering, and construction (AEC) industry. It offers specialized acoustics design software that enables the creation of physically accurate and perceptually realistic virtual acoustics. This software aids in minimizing risks and ensuring that designs adhere to all relevant regulations and certification standards. Additionally, it streamlines the process of importing, exporting, and reconfiguring models, ultimately saving time and costs for users. Treble's services find applications across various sectors, including automotive design, building architecture, immersive reality, and artificial intelligence, supporting studios and artists in delivering high-quality projects.

Wattalps

Series A in 2024
Wattalps is a technology company specializing in the development of lithium power systems tailored for small and medium-scale applications. Their product portfolio focuses on affordability, passive safety measures, efficient cooling mechanisms, extended lifespan, and robust cell protection features. Wattalps aims to simplify integration into vehicles or charging stations by offering standard and modular products, thereby facilitating swift, efficient, and cost-effective adoption of electric vehicle technologies and sustainable transportation solutions.

Oryl Photonics

Grant in 2024
Oryl Photonics specializes in developing laboratory instruments for pharmaceutical and biotech companies. Their core product provides a simple, reliable, and cost-effective method for measuring solubility, contributing to accelerated drug development and improved medicine. The company's unique technology preserves valuable substances during testing, offering a solubility measurement service that empowers researchers to make data-driven decisions and expedite product development.

MediWound

Grant in 2024
MediWound Ltd. is an integrated biopharmaceutical company based in Yavne, Israel, that specializes in developing, manufacturing, and commercializing innovative therapeutic products for severe burns and chronic wounds. Founded in 2000, the company is known for its flagship product, NexoBrid, which is an FDA-approved biopharmaceutical designed for the removal of eschar in adults with deep partial- and full-thickness thermal burns, offering a less invasive alternative to surgical interventions. MediWound also advances other product candidates, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic and hard-to-heal wounds, and MWPC003 for connective tissue disorders. The company aims to address significant unmet medical needs in these areas and improve patient outcomes.

Endoron Medical

Series A in 2024
Endoron Medical develops a catheter-based device to secure endografts during endovascular aneurysm repair. The treatment uses a stapling mechanism that mimics hand-sewn suturing by deploying multiple staples around the aortic circumference to achieve transmural attachment of the stent graft to the aortic wall. The device aims to reduce endoleaks and graft migration and to enable treatment of complex abdominal aortic aneurysm anatomies by improving fixation and sealing of the endograft.

Innatera

Series A in 2024
Innatera develops ultra-low-power neuromorphic processors for sensors. Founded in 2018 as a spin-off from Delft University of Technology, the company designs neuromorphic chips that mimic brain mechanisms for processing sensory data. The processors use continuous-time analog-mixed signal computing to replicate spiking neurons and synapses, enabling sensor data to be processed faster and with substantially less energy than conventional processors.

Qblox

Series A in 2024
Qblox is a Dutch scaleup specializing in quantum technology, focused on developing patented solutions for the scalable control of quantum computers. The company designs and manufactures modular control hardware that simplifies the experimental setups involving qubits, employing a distributed processor architecture to enhance gate fidelities. By advancing electronics with improved noise and drift performance, Qblox enables scientists to minimize crosstalk and achieve low-latency arbitrary control flows while optimizing measurement efficiency in dynamic readout conditions. The company aims to address the scientific and engineering challenges that must be overcome to transition from prototype quantum computers to powerful, practical quantum processors.

Bank of Memories

Grant in 2024
Bank of Memories operates a digital platform for long-term preservation of personal data, enabling users to store and organize various forms of digital memories, such as photos, videos, and documents. The platform employs blockchain technology and decentralized storage to ensure data security and longevity, allowing individuals and families to pass on their memories across generations. It offers features like digital monuments for commemorative purposes and a dedicated data room for secure storage, along with an explorer tool for navigating stored information and a whitepaper detailing the platform's technology.

King's College London

Grant in 2024
King's College London is a public research university in London, United Kingdom, and a constituent college of the University of London. Founded in 1829 by King George IV and the Duke of Wellington, it operates from multiple central London campuses and a campus in Denmark Hill, with a strong emphasis on medical and biomedical research and education. The institution supports a large community of students and staff and is known for its extensive graduate and postgraduate programmes. It is a founding member of the King's Health Partners academic health sciences centre and participates in major research and academic networks, including the Russell Group and Universities UK.

ProFuse Technology

Grant in 2024
ProFuse Technology develops cultured meat production technology that accelerates muscle fiber growth, shortens production time, and increases yield and production capacity, with the aim of improving meat quality and consistency while reducing costs for producers by streamlining the manufacturing process and enabling higher-throughput production of cultured meat.

Riverlane

Grant in 2024
Riverlane is a developer of quantum computing software focused on transforming experimental technology into commercial products. The company engineers innovative instruments in collaboration with quantum computer manufacturers, addressing the need for new hardware and software tools to manage the instability of qubits and rectify system defects at unprecedented speeds. Riverlane's software includes an ultra-low latency quantum operating system that accelerates quantum-classical hybrid algorithms, supporting hardware research and development. Additionally, the company creates algorithms designed to optimize the use of the entire quantum computing stack, assisting hardware partners in minimizing the system errors that currently challenge quantum computing capabilities.

Vitestro

Grant in 2024
Vitestro develops autonomous blood drawing technology aimed at transforming patient care.

Vitestro

Series A in 2024
Vitestro develops autonomous blood drawing technology aimed at transforming patient care.

DRONAMICS

Grant in 2024
Dronamics is a developer of advanced unmanned aerial systems aimed at transforming airfreight logistics. By creating a new type of small, unmanned cargo airplane that is highly fuel-efficient, Dronamics aims to democratize shipping in emerging markets. The aircraft can transport payloads of 350 kilograms over distances of 2,500 kilometers at costs significantly lower than traditional air transport, reducing shipping expenses by over 50%. Designed for autonomous flight, the aircraft can be remotely monitored and managed via satellite, making it suitable for challenging delivery scenarios, including remote and mountainous regions. As the first and only Strategic Partner for drones recognized by IATA, Dronamics is positioned to make a substantial impact in the commercial logistics sector.

RS Research

Grant in 2024
RS Research is a clinical-stage biotechnology company focused on developing nanomedicines for cancer treatment. Based in Istanbul, Turkey, it has developed a proprietary Sagitta drug-delivery platform that enables targeted chemotherapies across multiple indications. The company advances a portfolio of nanomedicine candidates through preclinical and clinical stages, with its lead program RS-0139 studied in Phase I oncology trials and supported by a GMP-certified production facility for clinical batch drug candidates. RS Research collaborates with international partners on co-development projects and offers ancillary services such as preclinical absorption, distribution, metabolism, and excretion testing, bioanalytical method development and validation, impurity and metabolite analysis, stability testing, toxicology studies, and patent-related due diligence and drafting support. The business aims to deliver targeted therapies with improved therapeutic indices through its nanocarrier technology and partnerships.

Multiverse Computing

Series A in 2024
Founded in 2019 with headquarters in San Sebastian, Spain, Multiverse Computing develops quantum computing software tailored to solve complex real-world challenges. Its software leverages probabilistic technology for portfolio optimization, risk analysis, and market simulation, serving clients across industries such as finance, energy, manufacturing, and logistics.

Smart Farm Robotix

Grant in 2024
Smart Farm Robotix specializes in manufacturing agricultural robots that tackle the challenges of manual weeding, herbicide use, and machine weeding. Their robots provide a cost-effective, reliable, and fully automated solution, equipped with innovative weed detection and elimination technology. This enables farmers to cultivate crops more efficiently and sustainably, while reducing dependence on manual labor and harmful chemicals.

FreezeM

Series A in 2024
FreezeM is a company focused on advancing the use of insects as a sustainable protein source for the animal feed industry. Recognizing the potential of insects to address the growing demand for alternative protein, FreezeM develops innovative preservation technologies that facilitate large-scale freezing of insect species. This process aims to create a reliable supply of ready-to-use suspended neonates and frozen eggs, akin to agricultural seed production, which can overcome challenges related to availability, cost, and regulatory constraints. By establishing global stocks of beneficial insects, FreezeM supports various applications, including protein for animal feed, biological pest control, and species preservation, ultimately contributing to a more sustainable food system.

Daze

Series A in 2024
Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.

Brite Solar

Series A in 2024
Brite Solar is a nanomaterials company specializing in innovative solar glass technologies. Its primary product is transparent solar glass for greenhouses, enabling self-sufficient greenhouse operations and reducing carbon footprints by minimizing reliance on external energy sources. The company's technology, based on nano-materials ink-jet printed onto glass panels, also has applications in auto-dimming glass and architectural glass for buildings.

Aldoria

Series A in 2024
Aldoria specializes in space situational awareness services. It collects, processes, and uses data on space debris, satellites, and derelicts to monitor potential hazards and enable operators to adjust orbital routes, ensuring safety and sustainability in space.

Wavess

Grant in 2024
Wavess is an innovative predictive marketing analytics platform that uses advanced AI algorithms and behavioral science to forecast campaign success before launch. It primarily serves digital marketing agencies, scale-ups, and enterprises in fintech, retail, and technology sectors, providing insights into audience preferences for personalized marketing strategies.

NETRIS Pharma

Series A in 2023
NETRIS Pharma S.A.S. is a biotechnology company based in Lyon, France, focused on the identification and development of therapeutic molecules aimed at treating various forms of cancer. Established in 2008, the company specializes in targeting dependence receptors, which are trans-membrane proteins that play a crucial role in cellular signaling and tumor control. NETRIS Pharma conducts both in vitro and in vivo research, as well as preclinical practices, to manufacture drugs specifically for the treatment of breast cancer, lung cancer, glioblastoma, and neuroblastoma. Through its innovative approach, the company aims to advance cancer therapies and contribute to improved patient outcomes in the pharmaceutical industry.

Lotus Microsystems

Series A in 2023
Lotus Microsystems offers miniaturized highly integrated point of load power converters. The devices are engineered for portable electronics manufacturers ready for usage whenever tiny power supply units are needed. Our devices offer up to 72% reduction in footprint compared to existing solutions with higher efficiency and reliability. Our plug and play solutions enable our customers to innovate their electronics without worrying about power supply units.

RespiQ

Grant in 2023
RespiQ is a healthtech company developing portable, non-invasive breath analysis technology that uses emission spectroscopy and artificial intelligence to detect biomarkers in breath for early identification and real-time monitoring of respiratory diseases such as COPD, as well as other conditions like asthma, lung cancer, and infectious diseases. Its device aims to be affordable and user-friendly, democratizing access to advanced diagnostics, while its platform can also identify digestive issues through breath biomarkers and support personalized guidance via an app that analyzes a digital breath print to deliver diet and health insights, enabling individuals to monitor changes and improve health outcomes.

Efenco

Grant in 2023
Efenco is a cleantech startup focused on enhancing the energy conversion efficiency of industrial furnaces and boilers while minimizing their carbon emissions. The company has developed a patented high-energy ray ceramic chip (HERC) that significantly reduces CO2 emissions and fuel costs by at least 18% in energy-intensive sectors, including electricity generation, steel manufacturing, pulp and paper production, ceramics, cement, and district heating. By leveraging principles from quantum and plasma physics, nanotechnology, and electrochemistry, Efenco's innovative technology captures and converts waste heat generated during natural gas combustion into a flux of ionizing radiation, thereby enabling industries to optimize energy usage and improve thermal conversion efficiency.

NEOGAP Therapeutics

Grant in 2023
NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.

Acorai

Grant in 2023
Acorai develops a non-invasive heart failure monitoring platform centered around direct intracardiac pressure monitoring. Its patented technology combines sensor technologies and machine learning to enable accurate, cost-efficient care, reducing re-hospitalization and mortality rates.

Skytree

Grant in 2023
Founded in 2014, Skytree develops direct air capture technology to recycle atmospheric CO2, providing a clean and reliable source for industries while contributing to global sustainability efforts.

ResoTher Pharma

Grant in 2023
ResoTher Pharma is a privately held biotechnology company based in Copenhagen, Denmark. The company specializes in developing peptide-based drugs derived from Annexin A1, an endogenous immunomodulator. These drugs are designed as resolution therapies for diseases where neutrophil-driven inflammation is a key pathological factor. ResoTher Pharma's primary focus is on addressing cardiovascular and inflammatory disorders that have significant unmet medical needs. Their patented peptide drugs target a G-protein coupled receptor expressed on leukocytes, aiming to mimic the body's natural response to resolving inflammation and promoting tissue repair.

RAIKU Packaging

Grant in 2023
RAIKU is a cleantech startup that produces 100% natural packaging material that has also great looks and shock absorption - most importantly, it gives 15-20 times more volume to its raw material making it one of the most resource efficient material uses in the world with high margins. Both the production is and products are clean making no harm to nature. RAIKU has raised over 1.2mln€ in the pre-seed stage, built a team of over 10 people, its own IP and clients are already using its packaging material. This material will up-end the 1 trillion € packaging sector.

SolasCure

Grant in 2023
Founded in 2017, SolasCure is a biotechnology company based in Wales, UK. It specializes in developing innovative hydrogel treatments for patients with chronic wounds. Its flagship product, Aurase, facilitates wound debridement, removing dead or infected tissue to enhance healing.

VSORA

Grant in 2023
VSORA develops digital signal processing IP and chips for 5G networks, featuring a multicore DSP architecture that removes the need for DSP coprocessors and a shared DSP development flow that unites signal processing and software engineers in one environment to speed time-to-market. The company aims to boost DSP computing power while reducing power consumption, improving system performance, and shrinking silicon footprint. Based in France, founded in 2015 by veteran DSP engineers, VSORA serves chipmakers designing next-generation digital communications systems.

FarmInsect

Series A in 2023
FarmInsect GmbH, established in 2019 and headquartered in Bergkirchen, Germany, specializes in automated insect breeding systems. The company develops machines and IoT solutions that enable regional farmers to rear insects on-site for use as animal feed, primarily for chickens, pigs, and fish. This sustainable approach aims to replace imported soy or fishmeal with locally produced protein feed, thereby enhancing the efficiency of animal husbandry while reducing environmental impact.

PASQAL

Grant in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

PrediSurge

Series A in 2023
PrediSurge is a software company that offers design and support solutions for physicians and medical device companies.

Kern Tec

Series A in 2023
Kern Tec specializes in transforming stone fruit pits from cherries, apricots, and plums into high-quality products. Their refined kernels are used as sustainable ingredients in baking, cosmetics, fertilizers, biomass, and food supplements industries.

Swisspod Technologies

Grant in 2023
Founded in 2019, Swisspod Technologies specializes in designing and developing Hyperloop vessels for tube-based transportation systems. The company aims to create energy-efficient, fully-electric pods, harnessing high-quality Swiss engineering to facilitate sustainable and efficient high-speed travel between cities.

Upmem

Grant in 2023
Upmem develops innovative Processing-In-Memory (PIM) solutions for datacenters, accelerating data-intensive applications by up to 10 times. Their technology reduces off-chip data movements, enhancing efficiency and reducing energy consumption.

Bound4Blue

Series A in 2023
Bound4Blue develops foldable wingsail systems for integration onto various vessels. Their technology harnesses wind power to reduce fuel consumption and pollutant emissions by up to 40%, with a payback period under five years.

Paptic

Series A in 2023
Paptic is a manufacturing company focused on creating innovative, wood-based renewable and recyclable products that aim to replace traditional paper and plastic materials. By developing plastic bags that merge the renewability and recyclability of paper with the functional benefits of plastics, Paptic addresses critical global environmental challenges, particularly the accumulation of plastic waste. The company's products enable customers to pursue sustainable practices without compromising their everyday needs for plastic bags.

Inbrain Neuroelectronics

Grant in 2023
Inbrain Neuroelectronics is a medical device company that designs and commercializes graphene-based neural interfaces and intelligent neuromodulation systems to treat brain disorders. The core platform is an implantable system that decodes brain activity with high resolution and provides focal, adaptive stimulation, enabling real-time precision neurology and autonomous therapy adjustments. This approach aims to maximize therapeutic outcomes while minimizing side effects for conditions such as Parkinson’s disease, epilepsy, and stroke rehabilitation. The company pursues strategic collaborations to extend its solutions to peripheral nerve and systemic disease applications, expanding the potential of neurotechnology and bioelectronics.

Stabl Energy

Venture Round in 2023
Stabl Energy develops innovative technology that substantially enhances battery storage systems.

Pulse

Grant in 2023
Pulse is a platform for furthering our understanding of bioprinting and its applications in space exploration and medicine.

Wooptix

Grant in 2023
Founded in Madrid, Spain in 2014, Wooptix develops innovative imaging technologies. The company specializes in creating three-dimensional modulation of images for enhanced volumetric photography and videography, enabling advanced image post-processing.

ELGAN Pharma

Grant in 2023
Elgan Pharma is a biotechnology company specializing in neonatology, primarily focused on addressing the medical challenges faced by premature infants. The company develops innovative therapies using nanotechnology aimed at preventing visual impairment, a significant concern for preterm babies. By targeting the multifactorial causes of visual disabilities, Elgan Pharma enables healthcare professionals to improve visual outcomes and reduce the risk of long-term disabilities in this vulnerable population. Through its advancements in late-stage development, the company is committed to enhancing the quality of care for premature infants and addressing critical developmental difficulties associated with their early birth.

Aviwell

Grant in 2023
Aviwell is a company focused on enhancing animal health and growth through the development of natural and sustainable solutions. Utilizing a microbiota-based platform powered by artificial intelligence and machine learning, Aviwell operates at the intersection of digital and life sciences. The company aims to provide insights that improve animal health and performance while addressing the agri-food industry's challenges in sustainably feeding a growing global population. By prioritizing health and sustainability, Aviwell seeks to offer effective solutions at a reduced cost, ultimately contributing to better nourishment for the planet.

Twinsity

Grant in 2023
Twinsity is a developer of a platform designed to visualize, inspect, and collaboratively manage high-resolution drone data and digital twins. The company focuses on enhancing infrastructure inspections and lifecycle management through the integration of artificial intelligence. Its virtual 3D inspection software provides accurate insights by consolidating a comprehensive image database, allowing all stakeholders involved in the inspection process to collaborate effectively. By centralizing communication, documentation, and inspection activities, Twinsity enables clients to streamline their operations, thereby improving the management and oversight of structures and assets.

Cellbox Solutions

Grant in 2023
Cellbox Solutions is a technology company that specializes in innovative logistic solutions for the global BioMed industry. It has developed a carbon dioxide incubator designed for the storage, isolation, handling, and analysis of biological materials. This incubator offers essential logistic services and ensures the proper handling of living cells, facilitating their storage, reproduction, transportation, and analysis. By enabling the transportation of living cells via various methods, including road, rail, and air, Cellbox Solutions supports healthcare providers in their efforts to deliver the latest therapies to patients.

Woodio

Grant in 2023
Woodio specializes in eco-friendly bathroom design solutions. It develops innovative, fully waterproof wood composite materials composed of real wood chips, offering customers sustainable and recyclable options for bathroom renovations.

EBAMed

Series A in 2023
EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

Escala Medical

Grant in 2023
Escala Medical is focused on developing a pioneering medical device aimed at treating pelvic organ prolapse (POP) in women. The company has created a minimally invasive, incision-free, and mesh-free repair system that addresses the long-standing need for effective POP treatment options. This innovative device allows for a nonsurgical approach that can be performed in outpatient and office settings, ensuring a safe and quick procedure with minimal discomfort for patients. By connecting the vaginal apex to the sacrospinous ligament without incisions, Escala Medical's technology preserves organ functionality while providing a much-needed solution for those affected by POP.

TreaTech

Series A in 2023
TreaTech is a Swiss cleantech company established in 2015 by engineers from the École Polytechnique Fédérale de Lausanne (EPFL). The company specializes in developing catalytic hydrothermal gasification (cHTG) technology that offers an innovative approach to wastewater treatment. This thermochemical process effectively transforms various types of liquid waste, including sewage sludge, into valuable by-products such as renewable gas, clean water, and mineral salts. TreaTech's solutions focus on eco-friendly waste disposal, aligning with sustainable development and circular economy principles. By recycling wastewater and its by-products, TreaTech enables clients to manage waste more sustainably while generating resources like fertilizers and biogas.

DTE ehf

Series A in 2023
DTE introduces breakthrough real-time process control analytics for metals production and processing towards Industry 4.0, through our robotic hardware and software solutions, automating current manual sampling processes for improved quality, cost, efficiency and safety.

Sensoneo

Series A in 2023
Sensoneo is a global provider of enterprise‑grade smart waste management solutions that help cities and businesses reduce costs and environmental impact. The company combines in‑house ultrasonic sensors—Single, Double, Quatro, and patent‑pending Micro‑sensors—with advanced software that delivers real‑time monitoring, analytics, route planning, and vehicle load optimization. By enabling data‑driven decisions, Sensoneo’s platform can cut waste‑collection costs by at least 30 % and lower carbon emissions by up to 60 %. Its solutions are deployed in numerous locations across Europe, North America, South America, the Middle East, Australia, and New Zealand, and include incentive programs that encourage waste reduction and streamline the entire waste lifecycle.

Cupffee

Grant in 2023
Cupffee specializes in manufacturing edible coffee cups and stirrers that are biodegradable and thermo-resistant. Their products aim to provide a delicious experience while promoting sustainability, as they generate no industrial waste and utilize leftover materials for other edible products.

VCG.AI

Grant in 2023
VCG.AI develops AI-powered software to accelerate the circular economy by turning industrial by-products and waste into valuable resources. Its platform, including the Value Chain Generator, analyzes thousands of data points to identify, evaluate, and implement circular business models and resource reuse strategies. It integrates real-time data analytics, technology readiness assessments, patent landscape analysis, supplier mapping, and value-chain tracking to shorten development cycles and improve resource efficiency. The solution supports organizations, cities, and regions in valorising by-products, sourcing circular materials, and enhancing circularity across supply chains. VCG.AI maintains a library of validated circular solutions and technologies and operates across Europe, helping customers accelerate market entry and create more sustainable, resilient operations.

3DSecret

Grant in 2023
3DSecret is developing cutting-edge technologies to uncover the stochastic patterns behind metastasis in order to predict the course of cancer.

Agurotech

Grant in 2023
Agurotech develops soil sensing technology, offering products that include robust sensors for reliable measurements, tailored irrigation recommendations, and continuous improvement of the irrigation process. Their platform provides a sensor-based weather station to offer local measurements of temperature, wind speed, direction, rainfall, and optimizes farm irrigation for crops and soils using farm data and local weather stations.

Inobiostar

Grant in 2023
Inobiostar focuses on research and experimental development services.

Norbite

Grant in 2023
Norbite is a biotechnology research firm that specializes in converting plastic waste into sustainable products through an innovative insect-based biorefinery process. The company's technology enables the production of sustainable goods by utilizing larvae that are bio-refined to extract proteins suitable for food and animal feed. By focusing on the transformation of plastic waste, Norbite aims to provide environmentally friendly solutions while addressing the growing concerns of waste management and sustainability. Through its unique approach, the firm contributes to the development of sustainable products and services that benefit both clients and the environment.

EyeLights

Series A in 2023
EyeLights is a developer of innovative motorcycle accessories focused on enhancing rider safety and experience through advanced technology. The company offers a head-up display GPS that projects crucial navigational and safety information directly into the rider's field of vision, allowing them to maintain focus on the road. This universal accessory alerts motorcyclists to potential hazards, such as sharp bends, traffic signals, and speed limits. Designed for easy installation in under five minutes, EyeLights is compatible with various helmet types, including full-face, convertible, and jet helmets. Its compact optical technology enables visibility of GPS data from over two meters away and features audio functionality for extended use of more than eight hours. The device is built to withstand adverse weather conditions, including rain and fog, while remaining lightweight at less than 100 grams. Overall, EyeLights aims to significantly enhance the safety and enjoyment of motorcycle riding.

Naco

Grant in 2023
Naco Technologies Ltd is a manufacturer and supplier of advanced nano-coating technologies, specializing in high-performance coatings for various industries including tooling, automotive, aerospace, and microchip production. Founded in 2009 and headquartered in Riga, Latvia, Naco develops multilayer and multicomponent coatings that enhance equipment performance by providing oil-enhanced, wear-protective, thermal barrier, and liquid-repellent properties. The company plays a significant role in the hydrogen sector by creating specialized coatings for Green Hydrogen systems, such as electrolyzers and fuel cells, which improve the reliability of these systems while minimizing the use of costly and scarce materials. In 2015, Naco Technologies was acquired by the Schaeffler Group, a Germany-based company, further strengthening its capabilities and market reach.

Samplix

Grant in 2023
Samplix is a biotechnology company based in Herlev, Denmark, that specializes in advanced sample preparation for single DNA and RNA molecules. The company has developed the proprietary Xdrop™ technology, which utilizes a unique "water-oil-water" droplet formation to create millions of reaction chambers for handling individual DNA molecules. This innovative technology allows for targeted enrichment of large DNA fragments, addressing the limitations of existing multi-molecule preparation methods. By enabling precise and sensitive sample preparation, Samplix empowers researchers to conduct more informed studies, facilitating the sequencing of genetic regions critical for understanding virus integration and minimizing unintended CRISPR edits. The Xdrop™ system includes both the instrumentation and consumables needed for effective single-molecule analysis, thereby enhancing the ease of use and efficiency in molecular research.

Nemysis

Grant in 2023
Nemysis is a Dublin-based specialty pharmaceutical company focused on developing and manufacturing food supplements, medical matrix products and prescription medicines. Founded in 2005, it pursues a staged development strategy to commercialize OTC and prescription products across different market segments addressing nutritional disorders and deficiencies. The company develops products such as a novel nanoparticulate oral iron supplement with a unique absorption mechanism to treat iron deficiency or anemia while minimizing gastrointestinal side effects, and glutenase capable of functioning in both the stomach and intestine to protect individuals with celiac disease or gluten sensitivity from inadvertent gluten exposure.

Smart Immune

Grant in 2023
Smart Immune is a clinical‑stage biotechnology company developing next‑generation hematopoietic stem cell–based biotherapies to improve outcomes for patients with severe diseases. Its flagship program uses T‑cell progenitors (ProTcells) to enable rapid, polyclonal, and safe immune reconstitution after transplantation. The platform integrates targeted conditioning, gene therapy, and genome editing to extend treatment options for inherited blood disorders, blood cancers, and other life‑threatening conditions.

inbiome

Grant in 2023
Inbiome is a trailblazing company in molecular diagnostics, specializing in proprietary molecular culture technology. This innovation enables swift bacterial testing and microbiome analysis, significantly expediting the process compared to traditional methods. The company's primary mission is to advance clinical microbiology by focusing on microbial detection and product development, thereby guiding clinicians towards more accurate and timely diagnoses. By offering advanced molecular technology for microbiome analysis, Inbiome aids in enhancing the understanding of bacteria in the human body, facilitating correct treatments, and mitigating unnecessary complications, costs, and anti-microbial resistance.

Quantune Technologies

Grant in 2023
Quantune Technologies is a deep tech startup specializing in optics and photonics technology. The company focuses on developing advanced infrared spectrometers that facilitate continuous and non-invasive health monitoring. By miniaturizing traditional laboratory equipment used for molecular analysis into compact modules, Quantune enables both biomedical consumer devices and industrial applications. This innovation allows clients to efficiently conduct real-time monitoring and analysis of chemical compounds and emissions, providing accessible solutions for a range of novel applications.

Miwa

Grant in 2023
Miwa is a company that offers a comprehensive retail solution aimed at reducing waste through the use of reusable containers. Its innovative approach focuses on minimizing single-use packaging by employing a circular economy strategy. Miwa's reusable containers are designed to be sealable and hygienic, working in conjunction with electronic dispensers installed in retail environments for the distribution of both food and non-food products in bulk. This system allows producers and retailers to store and dispense goods more sustainably, aligning with modern environmental standards while promoting efficient retail practices.

Molecular Attraction

Grant in 2023
Molecular Attraction is a research and development firm focused on creating innovative solutions for vector-borne disease control and eradication. The company specializes in identifying biological compounds that can influence the behavior of various vector organisms, including mosquitoes, ticks, flies, and rodents. By utilizing sustainable technology and chemical blends, Molecular Attraction aims to provide effective, long-lasting, and low-maintenance pest control solutions. Their approach is designed to enhance the efficacy of vector-borne disease management while prioritizing environmental sustainability and cost-effectiveness within the pest control industry.

GrayMatters Health

Grant in 2023
GrayMatters Health develops digital therapeutics for mental health and related neurological disorders, grounded in self-regulation of brain processes and brain biomarkers. The technology aims to deliver self-neuromodulation treatments that enhance efficacy, safety, and accessibility, enabling healthcare professionals to use neuroscience-based digital interventions within clinical practice and to complement conventional care with non-pharmacological options.

Qurv

Grant in 2023
Qurv, established in 2020, specializes in developing advanced image sensor technologies and integrated solutions. The company's core business is enabling next-generation computer vision applications, catering to the growing demands of autonomous and intelligent systems. Qurv's innovative technology, built on over eight years of research, leverages current CMOS manufacturing and advanced materials to deliver high-performance, reliable, and functional solutions for XR devices, service robots, and automotive industries.

Sunrise

Series A in 2023
Sunrise is a medical technology company focused on improving the diagnosis and management of sleep disorders, particularly sleep apnea, which affects nearly one billion people worldwide. The company has developed a 3-gram sensor that allows for rapid and accurate at-home diagnosis of sleep conditions, utilizing trigeminal drive analysis to detect respiratory events. This innovative device is clinically validated for use in both adults and children and provides a cost-effective alternative to traditional in-lab sleep studies. Users receive a single-use sensor delivered to their home, which connects easily to their phone for seamless operation. Following the test, Sunrise facilitates consultations with certified sleep doctors or connections to local sleep centers, addressing a critical need in a healthcare landscape where 80% of sleep apnea cases remain undiagnosed.

IDloop

Grant in 2023
IDloop develops and sells a contactless fingerprint sensor solution, utilizing 3D imaging, AI, and embedded technology. This solution is designed for business and government markets, offering secure multi-finger image capture to enhance security services.

Valo Therapeutics

Grant in 2023
Valo Therapeutics is an immunotherapy company focused on developing antigen-coated oncolytic viruses as therapeutic vaccines for cancer treatment. Founded in 2016 and based in Oxford, United Kingdom, with an additional office in Helsinki, Finland, the company utilizes its innovative Valo Tx platform, which includes PeptiCRAd, an engineered human oncolytic adenovirus. This platform is designed to induce systemic anti-tumor T cell responses by transforming oncolytic adenoviruses into targeted, tissue-specific cancer vaccines without requiring the production of multiple genetically modified viruses. Valo Therapeutics is also advancing other neoantigen strategies, including PeptiENV, in collaboration with Professor Vincenzo Cerullo from the University of Helsinki, to enhance therapeutic responses against various cancer types.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.